Symptom interval in pediatric patients with solid tumors: Adolescents are at greater risk of late diagnosis

Pediatric Blood and Cancer

Volumn 60, Issue 4, 2013, Pages 605-610

  Veneroni, Laura ^a,b   Mariani, Luigi ^a   Lo Vullo, Salvatore ^a   Favini, Francesca ^a   Catania, Serena ^a   de Pava, Marco Vajna ^a   Massimino, Maura ^a   Ferrari, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adolescents; Cancer; Diagnostic delay; Pediatric oncology; Symptom interval

Indexed keywords

ADOLESCENT; ARTICLE; CARCINOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; EWING SARCOMA; FEMALE; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SOFT TISSUE SARCOMA; SOLID TUMOR; SYMPTOM ASSESSMENT;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DELAYED DIAGNOSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; TIME FACTORS;

EID: 84873718943     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24312     Document Type: Article

References (26)

1. Bleyer A, Barr R. Highlights and challenges. In: Ries LAG, editor. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival 1975-2000. Bethesda, MD: National Cancer Institute NIH Inc. 2006.
2. Bleyer A, Tejeda H, Murphy SB, et al. National cancer clinical trials: Children have equal access; adolescents do not. J Adolesc Health 1997; 21: 366-373.
3. Bleyer A, Montello M, Budd T, et al. National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. Cancer 2005; 103: 1891-1897.
4. Liu L, Krailo M, Reaman GH, et al. Childhood cancer patients' access to cooperative group cancer programs: A population-based study. Cancer 2003; 97: 1339-1345.
5. Burke ME, Albritton K, Marina N. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer 2007; 110: 2385-2393.
6. Ferrari A, Bleyer A. Participation of adolescents with cancer in clinical trials. Cancer Treat Rev 2007; 33: 603-608.
7. Haimi M, Peretz Nahum M, Ben Arush MW. Delay in diagnosis of children with cancer: A retrospective study of 315 children. Pediatr Hematol Oncol 2004; 21: 37-48.
8. Goyal S, Roscoe J, Ryder WD, et al. Symptom interval in young people with bone cancer. Eur J Cancer 2004; 40: 2280-2286.
9. Dang-Tan T, Trottier H, Mery LS, et al. Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008; 51: 468-474.
10. Ferrari A, Miceli R, Casanova M, et al. The symptom interval in children and adolescents with soft tissue sarcomas. Cancer 2010; 116: 177-183.
11. Istituto Nazionale di Statistica. Indagine Multiscopo delle famiglie: Condizione di salute e ricorso ai servizi sanitari (Multipurpose Survey of Italian families: Health conditions and Health Service utilization). Roma: ISTAT; 1997.
12. Iman RL, Conover WJ. The use of the rank transform in regression. Technometrics 1979; 21: 499-509.
13. Dang-Tan T, Trottier H, Mery LS, et al. Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada. Int J Cancer 2010; 126: 1936-1943.
14. Loh AH, Ha C, Chua JH, et al. Delays in diagnosis of pediatric solid tumors in Singapore. J Pediatr Hematol Oncol 2009; 31: 734-738.
15. Saha V, Love S, Eden T, et al. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993; 68: 771-774.
16. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 1991; 119: 725-732.
17. Flores LE, Williams DL, Bell BA, et al. Delay in the diagnosis of pediatric brain tumors. Am J Dis Child 1986; 140: 684-686.
18. Fajardo-Gutierrez A, Sandoval-Mex AM, Mejia-Arangure JM, et al. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol 2002; 39: 25-31.
19. Bisogno G, Compostella A, Ferrari A, et al. Rhabdomyosarcoma in adolescents: A report from the AIEOP Soft Tissue Sarcoma Committee. Cancer 2012; 118: 821-827.
20. Morgan S, Davies S, Palmer S, et al. Sex, drugs, and rock "n" roll: Caring for adolescents and young adults with cancer. J Clin Oncol 2010; 28: 4825-4830.
21. Abrams AN, Hazen EP, Penson RT. Psychosocial issues in adolescents with cancer. Cancer Treat Rev 2007; 33: 622-630.
22. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials. Cancer 2006; 107: 1645-1655.
23. Ferrari A, Dama E, Pession A, et al. Adolescents with cancer in Italy: Entry into the national cooperative paediatric oncology group AIEOP trials. Eur J Cancer 2009; 45: 328-334.
24. Ferrari A, Meazza C, Vajna de Pava M, et al. Two cases of adolescents with paratesticular rhabdomyosarcoma inadequately treated: The problem of referral. J Adol Young Adult Oncol 2012; 1: 152-154.
25. Ferrari A, Aricò M, Dini G, et al. Upper age limits for accessing pediatric oncology centers in Italy: A barrier preventing adolescents with cancer from entering national cooperative AIEOP trials. Pediatr Hematol Oncol 2012; 29: 55-61.
26. Ferrari A, Bisogno G, Meazza C, et al. The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: The Italian pediatric oncology view. Expert Rev Anticancer Ther 2012; 12: 243-254.